EP Lab Digest recently published Gender Matters: Why Afib Is More Fatal for Women, authored by StopAfib.org founder Mellanie True Hills. In it, she discussed the research into why atrial fibrillation and afib-related strokes are more deadly for women and what can be done. Topics include: Stroke and bleeding risk assessment tools, including CHADS2, CHA2DS2-VASc, …
Read More
Set your DVRs, or watch live, on Saturday, March 23, at 8AM ET/PT, as the Discovery Channel unveils the atrial fibrillation documentary, “A Heartbeat Away From Stroke”. StopAfib.org was thrilled to collaborate with Discovery Channel and other organizations on this documentary. Learn more at StopAfib.org Collaborates on Discovery Channel Atrial Fibrillation Documentary
Read More
Our January EP Lab Digest Patient Perspective column, Stuck in the Middle: Afib Patients on Rate Control, focuses on how rate control treatment (such as beta blockers) alone impacts the quality of life of those living with atrial fibrillation. The column also explores things doctors and patients may wish to consider in determining an appropriate …
Read More
As a patient, you probably see lots of hype-filled reports about various drugs. After a drug is approved, there’s an inevitable blitz of negative publicity which often scares people away from important new solutions that could help them. There has been so much news lately about Multaq (dronedarone), the drug designed to provide the benefits …
Read More
Mellanie True Hills, founder of StopAfib.org, recently spoke at the Fourth Annual Western Atrial Fibrillation Symposium. Many of her remarks to this medical conference are summarized in an article just published in EP Lab Digest. You may wish to share it with family and friends who need to understand what it's like to live with …
Read More
Note: In meetings with the FDA last week, representatives from WomenHeart and StopAfib.org became aware of the risk that potential funding cuts may significantly delay the FDA's work in reviewing and approving afib drugs and devices. Because of the potential impact on the afib community, we are publishing comments from WomenHeart as to what those …
Read More
Researchers at the Comprehensive Arrhythmia Research and Management Center (CARMA) in Utah have been studying the relationship between atrial fibrillation, atrial fibrosis, and catheter ablation outcomes for many years. Now, they’ve applied their knowledge of quantifying atrial fibrosis to stroke risk assessment and found that the amount of atrial fibrosis, not type of afib, is …
Read More
New research from Denmark shows that CHADS2 underestimates stroke risk. In the study, atrial fibrillation patients who were at intermediate risk with the CHADS2 scoring system had more than twice the stroke rate of those defined by the enhanced CHA2DS2-VASc tool as being at intermediate risk. While CHADS2 deemed 32.3% of patients to have intermediate …
Read More
By Mellanie True Hills I just got home from a one-week multi-city trip and have so much catching up to do. But with the furor over the new airport security screening procedures that have just gone into effect in the US, I have some thoughts that I simply must share before my head explodes. This …
Read More
New medical guidelines from the European Society of Cardiology (ESC) incorporating the latest afib research put Europe ahead of the U.S. when it comes to standardized treatment of atrial fibrillation. Stroke prevention and symptom relief are at the heart of the new ESC guidelines, which also make it clear that the risk of stroke for …
Read More